drugset / Trial / NCT00483600
Pharmacokinetic Study of Fondaparinux in Outpatients With Renal Dysfunction
Non-randomizedSingle-groupOpen-labelBasic science
Summary
To determine the appropriate dose and safety of a preventative dose of fondaparinux, an anticoagulant medication (blood thinner) in patients with kidney disease.
Timeline
- Start
- 2007-08
- Primary completion
- —
- Completion
- 2008-08
Outcome
Outcome not reported
Stopped (Enrollment): “unable to enroll”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fondaparinux | Other / unclassified | 2.5 mg | Subcutaneous |